Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × 1-dodecylpyridoxal × Clear all

Phase

Status

Completed 13 Unknown 11 Terminated 7 Recruiting 4 Active not recruiting 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Cyclophosphamide 100 Radiotherapy 99 Cisplatin 97 pembrolizumab 92 Paclitaxel 74 Carboplatin 73 Nivolumab 67 Gemcitabine 67 Magnetic Resonance Spectroscopy 64 Fluorouracil 63 Dexamethasone 57 Bevacizumab 56 Radiosurgery 53 Docetaxel 51 Rituximab 48 Oxaliplatin 47 Leucovorin 47 fludarabine 45 Capecitabine 44 Biopsy 44 Doxorubicin 37 Drug Therapy 36 durvalumab 35 Etoposide 34 Cytarabine 34 fludarabine phosphate 33 Radiation 33 Pemetrexed 32 Lenalidomide 32 Specimen Handling 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05201001 2023-09-11

APX005M

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Phase 2 Withdrawn

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡